Summary

Clinical Trial Equipment & Ancillary Solutions Market Summary

The global clinical trial equipment & ancillary solutions market size was valued at USD 3.21 billion in 2024 and is projected to reach USD 6.88 billion by 2033, growing at a CAGR of 8.92% from 2025 to 2033. The growth of the market is due to the increasing complexity and globalization of clinical trials, which demand highly specialized, protocol-specific equipment and logistics support.

The rapid adoption of decentralized and hybrid trial models requires remote monitoring devices, wearable sensors, and home-use diagnostic kits, significantly expanding the scope of ancillary services. The transformation of clinical trial models, especially the increase of decentralized and hybrid trials, has significantly raised the demand for specialized equipment and support services that facilitate remote, site-less, and home-based research settings. The traditional model, which relied heavily on centralized trial sites, is being replaced by more patient-focused approaches, requiring remote monitoring devices, mobile health kits, wearables, and courier-enabled logistics for biological samples. For example, the U.S. FDA has promoted decentralized clinical trials (DCTs) through its 2023 draft guidance, urging sponsors to adopt digital health technologies and remote care tools to enhance patient access and data quality. These developments are leading CROs and sponsors to acquire reliable, temperature-sensitive packaging, validated medical devices for home use, and real-time tracking systems to oversee equipment shipments across different regions. This shift has transformed the role of clinical trial equipment suppliers from passive vendors into active, integrated service partners responsible for ensuring regulatory compliance, proper calibration, and delivery schedules aligned with study protocols.

Additionally, government and non-profit funding organizations are increasingly supporting early-stage research, translational medicine, and investigator-initiated trials, all of which depend on timely access to ancillary trial supplies. Initiatives like the NIH’s All of Us Research Program and the European Union’s Horizon Europe framework are expanding the boundaries of patient cohort diversity and precision diagnostics, which require adaptive and flexible equipment supply strategies. For example, Horizon Europe allocates nearly USD 111.49 billion (€95 billion) toward science and innovation through 2027, with multiple projects focused on personalized medicine, wearable monitoring, and telehealth-integrated clinical trials. These initiatives generate demand for site-ready kits, cloud-connected monitoring devices, and digitally traceable shipping for reagents and biologics.

Global Clinical Trials Equipment & Ancillary Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical trial equipment & ancillary solutions market report based on type, phase and region.

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Sourcing
o Procurement
o Equipment
o Ancillaries
o Rental
o Equipment
o Ancillaries
• Supply/Logistics
o Transportation
o Packaging
o Others
• Service
o Calibrations
o Equipment servicing
o Others
• Others
• Phase Outlook (Revenue, USD Million, 2021 - 2033)
• Phase I
• Phase II
• Phase III
• Phase IV
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Norway
o Sweden
• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Value chain based analysis (Model 2)
1.7.3. Multivariate Analysis (Model 3)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Clinical Trial Equipment & Ancillary Solutions Market: Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Clinical Trial Equipment & Ancillary Solutions Market Dynamics
3.2.1. Market Driver Impact Analysis
3.2.2. Market Restraint Analysis
3.3. Technological Landscape
3.4. Pricing Model Analysis
3.5. Clinical Trial Equipment & Ancillary Solutions Market: Analysis Tools
3.5.1. Porter’s Five Forces Analysis
3.5.2. PESTEL Analysis
Chapter 4. Clinical Trial Equipment & Ancillary Solutions Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Clinical Trial Equipment & Ancillary Solutions Market Type Movement Analysis
4.3. Global Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. Sourcing
4.4.1. Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD million)
4.4.2. Procurement
4.4.2.1. Procurement Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2.2. Equipment
4.4.2.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2.3. Ancillaries
4.4.2.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Rental
4.4.3.1. Rental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3.2. Equipment
4.4.3.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3.3. Ancillaries
4.4.3.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Supply/Logistics
4.5.1. Supply/Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Transportation
4.5.2.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Packaging
4.5.3.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Others
4.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Service
4.6.1. Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Calibrations
4.6.2.1. Calibrations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Equipment servicing
4.6.3.1. Equipment Servicing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.4. Others
4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Others
4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Clinical Trial Equipment & Ancillary Solutions Market Phase Movement Analysis
5.3. Global Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Phase, 2021 to 2033 (USD Million)
5.4. Phase I
5.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Phase II
5.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Phase III
5.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Phase IV
5.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Clinical Trial Equipment & Ancillary Solutions Market: Regional Estimates & Trend Analysis by Type, Phase
6.1. Regional Market Dashboard
6.2. Global Regional Market Snapshot
6.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Europe
6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. MEA
6.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.1.1. Market Leaders
7.1.2. Emerging Players
7.2. Company Market Share/Assessment Analysis, 2024
7.3. Company Profiles
7.3.1. Ancillare, LP
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Service benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Imperial CRS, Inc.
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Service benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Woodley Equipment Company Ltd.
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Service benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Thermo Fisher Scientific, Inc.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Service benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Parexel International (MA) Corporation
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Service benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Emsere
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Service benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Quipment SAS
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Service benchmarking
7.3.7.4. Strategic initiatives
7.3.8. IRM
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Service benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Marken
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Service benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Myonex
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Service benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Yourway
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Service benchmarking
7.3.11.4. Strategic initiatives